Credent Connect N Care IPO Day 1: Subscription status, review — here's what you need to know
Credent Connect N Care IPO opened on August 13, 2026, with total subscription reaching 1.82x by end of Day 1. Retail (2.62x) and bHNI (1.54x) led the subscription, showing strong intraday momentum. The company, a healthcare logistics provider, reported FY26 revenue of ₹214.16 crores. Proceeds will fund working capital and subsidiary investments.

*this image is generated using AI for illustrative purposes only.
Credent Connect N Care IPO opened for subscription on August 13, 2026, registering a total subscription of 1.82x by the end of Day 1. The issue saw a notable uptick in momentum during trading hours, with Non-Institutional Investors (bHNI) jumping +19.4% from the morning snapshot and Retail investors picking up pace with a +16.4% increase. The healthcare logistics provider’s public issue is priced between ₹179.00000 and ₹189.00000.
Subscription Status
The IPO saw steady interest from retail investors on its opening day, racing ahead in the latter half of the session. Here is the breakdown of the Day 1 subscription:
| Category | Subscription Multiple |
|---|---|
| QIB | 1.00x |
| NII (bHNI) | 1.54x |
| NII (sHNI) | 0.79x |
| Retail | 2.62x |
| Total | 1.82x |
Intra-day Timeline
Subscription activity remained consistent throughout the trading hours on August 13, 2026, with significant movement between 9:45 AM and 10:45 AM.
| Time (IST) | QIB | NII (bHNI) | Retail | Total |
|---|---|---|---|---|
| 09:45 | 1.00x | 1.29x | 2.25x | 1.59x |
| 10:45 | 1.00x | 1.54x | 2.62x | 1.82x |
Subscription Progression
| Day | Date | QIB | NII (bHNI) | NII (sHNI) | Retail | Total |
|---|---|---|---|---|---|---|
| Day 1 | 13-08-2026 | 1.00x | 1.54x | 0.79x | 2.62x | 1.82x |
About the Company
Credent Connect N Care is a healthcare services provider engaged in delivering integrated logistics, workforce solutions, and technology-enabled support to healthcare institutions across India. Founded in 2015, the company provides comprehensive operational services to diagnostic laboratories, IVD companies, pharmaceutical firms, and clinics. Its offerings include home sample collection, operations & supply chain services, and specialized inter-state logistics. The company employs 2589 riders as of June 30, 2026, and is managed by MD Tarun Sharma and CFO Karan Sharma.
Financial Highlights
The company has shown significant revenue growth in recent years. Below are the consolidated financial highlights:
| Year Ended | Revenue from Operations (₹ crores) | Total Profit (₹ crores) | Total Equity (₹ crores) |
|---|---|---|---|
| March 31, 2026 | 214.16 | 18.45 | 43.79 |
| March 31, 2025 | 77.94 | 2.25 | 15.90 |
| March 31, 2024 | 75.73 | 2.66 | 13.66 |
Revenue surged from ₹75.73 crores in FY24 to ₹214.16 crores in FY26, driven by expanded operations across multiple states including Maharashtra, Uttar Pradesh, and Delhi.
Objects of the Issue
The proceeds from the IPO will be utilized for the following purposes:
- To meet Working Capital Requirements: ₹37.00 crores
- Investment in wholly owned subsidiary for working capital requirement: ₹26.80 crores
- Repayment and/or prepayment of borrowings: ₹6.00 crores
- Investment in wholly owned subsidiary for capital expenditure requirements for machinery: ₹3.00 crores
- General corporate purposes: Amount not specified in lakhs
Risk Factors
Investors should consider the following key risks associated with the company:
- High Customer Concentration Risk: The company derives 81.76% of revenue from its top 10 customers in Fiscal 2026 without firm commitments.
- Dependence on Healthcare Industry Volumes: Business performance is tied to diagnostic testing volumes and outsourcing trends in the healthcare sector.
- Working Capital Intensive Operations: Trade receivables stood at ₹5,882.73 lakhs as of March 31, 2026, posing liquidity risks if realization is delayed.
Offer Details
- Price Band: ₹179.00000 - ₹189.00000
- Issue Size: 322200 - 500000
- Min Bid Qty: 1200
- IPO Open Date: 2026-08-13
- IPO Close Date: 2026-08-17
How might the high customer concentration risk (81.76% from top 10 clients) impact Credent Connect's revenue stability post-listing if key healthcare partners renegotiate contracts?
Given the surge in revenue from ₹77.94 cr to ₹214.16 cr in FY26, can the company sustain this growth trajectory without further diluting margins due to working capital intensity?
Will the significant trade receivables of ₹5,882.73 lakhs pose a liquidity challenge for the company in the near term, and how does the IPO proceeds allocation address this risk?


























